BIT
Click for more information
0.00% 3.3¢ biotron limited

Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-136

  1. eob18
    1,081 Posts.
    lightbulb Created with Sketch. 375
    clock Created with Sketch.
    01/10/18
    17:05
    Post #: 35953139
    Only minor R&D rebate which is due in this quarter and generally between 1.2m-1.6m

    Options are looking strong for conversation, time will tell by end of the week. Strong finish again this afternoon.
    BIT Price at posting: 6.2¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
NEWS Hillcrest Energy Unveils Power Factor Correction Prototype to Meet Growing Demand
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $29.77M
Open High Low Value Volume
3.4¢ 3.4¢ 3.1¢ $74.61K 2.300M

Buyers (Bids)

No. Vol. Price($)
4 280031 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 96500 1
View Market Depth
Last trade - 15.22pm 12/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.